FIELD: chemistry.
SUBSTANCE: invention refers to the methods for preparation of X-ray amorphous carvedilol [(+)-1-(9H-carbazole-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amine}propane-2-ol] modification and can be used in pharmaceutical industry. Method involves the evaporation of carvedilol parent drug in vacuum device at temperature 80-200oC, residual pressure 5 - 5×10-4 Torr in a inert gas flow fed with the rate from 10 to 100 ml/min with following condensation at -196 - +25oC. The process results in obtaining of powder of X-ray amorphous carvedilol [(±)-1-(9H-carbazole-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amine}propane-2-ol] modification with particle size less than 5 mcm.
EFFECT: enhancing of bioactivity.
7 ex, 8 dwg
Title | Year | Author | Number |
---|---|---|---|
ROENTGEN-AMORPHOUS WATER-FREE MODIFICATION OF 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[4-METHYL-3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]-AMINO]-PHENYL]BENZAMIDE OF METHANE SULFONATE AND METHOD OF OBTAINING IT | 2008 |
|
RU2365587C1 |
METHOD FOR DETERMINING CARVEDILOL BY MEANS OF INVERSION VOLTAMPEROMETRIA | 2007 |
|
RU2334510C1 |
CRYSTALLINE BETA-MODIFICATION OF 7-BROMO-1,3-DIHYDRO-5-(2-CHLOROPHENYL)-2H-1,4-BENZODIAZEPIN-2-ONE AND SYNTHESIS METHOD THEREOF | 2010 |
|
RU2430094C1 |
METHOD FOR PREPARING PHARMACEUTICAL PRODUCT CARVEDILOL AND INTERMEDIATE COMPOUND | 1998 |
|
RU2216539C2 |
METHOD FOR PREPARING PHARMACEUTICAL PRODUCT | 1998 |
|
RU2245875C2 |
CRYSTALLINE MODIFICATION OF 3β-HYDROXY-5-ANDROSTEN-17-ONE FVII AND METHOD FOR PRODUCTION THEREOF | 2013 |
|
RU2528990C1 |
METHOD OF OBTAINING A CRYSTALLINE MODIFICATION OF FIII 3Β-HYDROXY-5-ANDROSTEN-17-ONE (DEHYDROEPIANDROSTERONE, PRASTERONE, DHEA). | 2022 |
|
RU2820659C2 |
PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING CARDIOVASCULAR DISEASES | 2011 |
|
RU2491070C2 |
METHOD OF SYNTHESIS OF 4-HYDROXY-9H-CARBAZOLE | 1998 |
|
RU2204551C2 |
NANOSIZE WEAKLY CRYSTALLINE MODIFICATION OF 4-METHYL-N-[3-(4-METHYLIMIDAZOL-1-YL)-5-(TRIFLUOROMETHYL)PHENYL]-3-[(4-PYRIDIN-3-YLPYRIMIDIN-2-YL)AMINO]BENAZAMIDE HYDROCHLORIDE MONOHYDRATE, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION BASED THEREON | 2013 |
|
RU2551359C1 |
Authors
Dates
2009-09-10—Published
2006-07-03—Filed